{"id":3972,"date":"2020-10-19T07:31:17","date_gmt":"2020-10-19T07:31:17","guid":{"rendered":"https:\/\/blog.caixaresearch.org\/?p=3972"},"modified":"2021-03-23T11:16:09","modified_gmt":"2021-03-23T11:16:09","slug":"la-fundacio-la-caixa-tambe-en-la-lluita-contra-el-cancer-de-mama","status":"publish","type":"post","link":"https:\/\/blog.caixaresearch.org\/ca\/la-fundacio-la-caixa-tambe-en-la-lluita-contra-el-cancer-de-mama\/","title":{"rendered":"La Fundaci\u00f3 \u201dla Caixa\u201d, tamb\u00e9 en la lluita contra el c\u00e0ncer de mama"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">El 2019 es van diagnosticar a Espanya 33.307 nous casos de c\u00e0ncer de mama. De fet, segons l\u2019<\/span><a href=\"http:\/\/observatorio.aecc.es\/es\/\"><span style=\"font-weight: 400;\">Observatori del C\u00e0ncer AECC<\/span><\/a><span style=\"font-weight: 400;\">, des de l\u2019any 2012 fins al 2019 hi ha hagut un increment del 7,5 % dels casos i es calcula que 1 de cada 8 dones desenvoluparan un c\u00e0ncer de mama al llarg de la vida, el que significa que aquest c\u00e0ncer impacta cada any la vida de 2,1 milions de dones al m\u00f3n, segons l&#8217;OMS.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-3967 aligncenter\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/Card_DmCancerMama_CAT.jpg\" alt=\"\" width=\"400\" height=\"400\" srcset=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/Card_DmCancerMama_CAT.jpg 800w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/Card_DmCancerMama_CAT-300x300.jpg 300w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/Card_DmCancerMama_CAT-150x150.jpg 150w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/Card_DmCancerMama_CAT-768x768.jpg 768w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><\/p>\n<p><span style=\"font-weight: 400;\">El gran problema d\u2019aquests tumors mamaris \u00e9s que poden derivar en met\u00e0stasi i causar la mort. Per sort, la taxa de superviv\u00e8ncia segueix augmentant gr\u00e0cies a la millora dels tractaments i a una detecci\u00f3 preco\u00e7 dels tumors. M\u00e9s del 85 % de les dones sobreviu 10 anys despr\u00e9s de la diagnosi.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Per la seva banda, la Fundaci\u00f3 \u201dla Caixa\u201d, des de l\u2019\u00c0rea de Recerca i Salut, ha donat suport a 36 projectes i assaigs cl\u00ednics de nous medicaments per lluitar contra el c\u00e0ncer de mama dels quals s\u2019han beneficiat 263 pacients, en els \u00faltims 3 anys, amb un import de 3,5 milions d\u2019euros. Avui, en el Dia Mundial del C\u00e0ncer de Mama, entrevistem diversos investigadors que treballen amb el suport de la Fundaci\u00f3 \u201dla Caixa\u201d per convertir, en un futur no molt lluny\u00e0, potser, el c\u00e0ncer de mama en una malaltia cr\u00f2nica.<\/span><\/p>\n<p><b>Assajos cl\u00ednics, una soluci\u00f3 anticipada\u00a0<\/b><\/p>\n<p style=\"text-align: center;\"><iframe loading=\"lazy\" src=\"https:\/\/www.youtube.com\/embed\/Yhuv7t8bqfE\" width=\"400\" height=\"500\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p><span style=\"font-weight: 400;\">Elena Garralda, directora de la Unitat de Recerca de Ter\u00e0pia Molecular del C\u00e0ncer (UITM) &#8211; Fundaci\u00f3 <\/span><span style=\"font-weight: 400;\">\u201dla Caixa\u201d <\/span><a href=\"https:\/\/www.vhio.net\/es\/\"><span style=\"font-weight: 400;\">Vall d\u2019Hebron Institut d\u2019Oncologia<\/span><\/a><span style=\"font-weight: 400;\"> (VHIO), <\/span><span style=\"font-weight: 400;\">duu a terme assajos cl\u00ednics per al desenvolupament de ter\u00e0pies personalitzades, m\u00e9s segures i eficients contra el c\u00e0ncer. Nom\u00e9s en els \u00faltims 3 anys, la unitat que lidera Garralda ha participat en 30 assajos per a nous tractaments de c\u00e0ncer de mama. Aquests assajos s\u00f3n l&#8217;avantsala de la comercialitzaci\u00f3 dels f\u00e0rmacs i alhora han ofert una soluci\u00f3 innovadora i anticipada a les 263 pacients que han participat en aquests estudis.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cLes ter\u00e0pies m\u00e9s noves, les ter\u00e0pies que s\u2019estan investigant en aquest moment, el m\u00e9s innovador sempre arriba a trav\u00e9s d\u2019un assaig cl\u00ednic. De fet, hi ha estad\u00edstiques que diuen que els pacients que participen en assaigs cl\u00ednics s\u00f3n els pacients que viuen m\u00e9s, perqu\u00e8 tenen acc\u00e9s a f\u00e0rmacs als quals no podrien accedir\u201d, explica Garralda.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">En els \u00faltims 10 anys, la UITM &#8211; \u201dla Caixa\u201d s\u2019ha convertit en un centre de refer\u00e8ncia en oncologia translacional a escala internacional. Durant aquest temps aquesta unitat ha participat en el desenvolupament de m\u00e9s de 20 f\u00e0rmacs, dels quals gran part es fan servir en ter\u00e0pies dirigides a biomarcadors tumorals espec\u00edfics. \u201c\u00c9s la primera vegada que certs pacients amb tumors metast\u00e0tics estan sobrevivint m\u00e9s de 10 anys, i en alguns casos estan potencialment curats. L\u2019impacte d\u2019aquests f\u00e0rmacs ha estat brutal\u201d.<\/span><\/p>\n<p><b>Un test per a un millor tractament\u00a0<\/b><\/p>\n<p style=\"text-align: center;\"><iframe loading=\"lazy\" src=\"https:\/\/www.youtube.com\/embed\/JKN3k7zPgu4\" width=\"400\" height=\"500\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p><span style=\"font-weight: 400;\">Alba Llop, investigadora postdoctoral del <\/span><a href=\"https:\/\/www.vhio.net\/es\/\"><span style=\"font-weight: 400;\">Vall d\u2019Hebron Institut d\u2019Oncologia (VHIO)<\/span><\/a><span style=\"font-weight: 400;\">, \u00e9s la l\u00edder d\u2019un projecte que ha rebut el suport del programa CaixaImpulse, inicialment a la convocat\u00f2ria Validate 2017 i m\u00e9s recentment a la convocat\u00f2ria Consolidate 2019. L\u2019objectiu \u00e9s el desenvolupament d\u2019un test, anomenat <a href=\"https:\/\/caixaimpulse.com\/en-US\/web\/guest\/projects\/-\/caixaimpulse\/project\/253873\" target=\"_blank\" rel=\"noopener\">RAD51predict<\/a>, que permet identificar el millor tractament per a algunes pacients amb c\u00e0ncer de mama.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cGr\u00e0cies al desenvolupament d\u2019aquest test, podem identificar biomarcadors a les c\u00e8l\u00b7lules tumorals i seleccionar millor els pacients per a un cert tipus de medicaments coneguts com a inhibidors de PARP\u201d, declara Llop. Aquest nou test de diagn\u00f2stic ajudar\u00e0 a estendre l\u2019\u00fas terap\u00e8utic d\u2019inhibidors de PARP i guiar\u00e0 els onc\u00f2legs en les seves recomanacions de tractament. S\u2019estima que m\u00e9s del deu per cent de totes les pacients amb c\u00e0ncer podrien beneficiar-se\u2019n.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cEl meu desig per al futur \u00e9s poder prevenir el c\u00e0ncer. En aquells casos que no sigui possible, aleshores, tant de bo puguem detectar-lo d\u2019hora i puguem donar el tractament adequat a cada pacient, i gr\u00e0cies a tests com el RAD51predict podrem seleccionar pacients que es beneficiaran de medicaments espec\u00edfics\u201d, conclou Llop.<\/span><\/p>\n<p><b>El mapa de les c\u00e8l\u00b7lules tumorals\u00a0<\/b><\/p>\n<p style=\"text-align: center;\"><iframe loading=\"lazy\" src=\"https:\/\/www.youtube.com\/embed\/gzC-EG1iPPY\" width=\"400\" height=\"500\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p><span style=\"font-weight: 400;\">Roger Gomis, cap del laboratori Control de <\/span><a href=\"https:\/\/www.irbbarcelona.org\/es\/research\/growth-control-and-cancer-metastasis\"><span style=\"font-weight: 400;\">creixement i met\u00e0stasi del c\u00e0ncer<\/span><\/a><span style=\"font-weight: 400;\"> i professor de <\/span><a href=\"https:\/\/www.icrea.cat\/es\"><span style=\"font-weight: 400;\">recerca a la Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats (ICREA)<\/span><\/a><span style=\"font-weight: 400;\"> a l\u2019<\/span><a href=\"https:\/\/www.irbbarcelona.org\/en\"><span style=\"font-weight: 400;\">Institut de Recerca Biom\u00e8dica<\/span><\/a><span style=\"font-weight: 400;\"> (IRB) de Barcelona, lidera el projecte \u201cMapa de Dest\u00ed Cel\u00b7lular en Met\u00e0stasi\u201d que va rebre el 2018 un ajut Health Research de la Fundaci\u00f3 \u201dla Caixa\u201d.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">En aquesta recerca, Gomis vol tra\u00e7ar l\u2019evoluci\u00f3 de les c\u00e8l\u00b7lules tumorals en el c\u00e0ncer de mama per identificar les que creixen i es disseminen per met\u00e0stasi, com tamb\u00e9 les que romanen en un per\u00edode de lat\u00e8ncia. \u201cUna de les majors oportunitats en el control del c\u00e0ncer de mama metast\u00e0tic rau precisament a allargar el temps de lat\u00e8ncia metast\u00e0tica, \u00e9s a dir, transformar una malaltia puntual i aguda en una malaltia cr\u00f2nica, que s\u2019allarga en el temps\u201d, explica Gomis.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Si coneixem millor els mecanismes moleculars que causen la met\u00e0stasi, podrem dissenyar f\u00e0rmacs m\u00e9s espec\u00edfics. L\u2019objectiu final \u00e9s millorar el control cl\u00ednic de les pacients amb c\u00e0ncer. \u201cEn el cas del c\u00e0ncer de mama, els aven\u00e7os cl\u00ednics i cient\u00edfics, en termes de prevenci\u00f3 i de tractament, han perm\u00e8s que actualment, al cap de deu anys que la malaltia s\u2019hagi manifestat, el 85 % de les pacients segueixin vives i amb bona qualitat de vida\u201d, declara Gomis.<\/span><\/p>\n<p>&nbsp;<\/p>\n<div>\n<div class=\"gmail_default\">\u200b<em><strong>Aquest article tamb\u00e9 apareix a la p\u00e0gina <a href=\"https:\/\/caixaimpulse.com\/en-US\/web\/guest\/news-events\/-\/caixaimpulse\/news\/556717\" target=\"_blank\" rel=\"noopener\">web de CaixaImpulse<\/a>.<\/strong><\/em>\u200b<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>El 2019 es van diagnosticar a Espanya 33.307 nous casos de c\u00e0ncer de mama. De fet, segons l\u2019<a href=\"http:\/\/observatorio.aecc.es\/es\/\">Observatori del C\u00e0ncer AECC<\/a>, des de l\u2019any 2012 fins al 2019 hi ha hagut un increment del 7,5 % dels casos i es calcula que 1 de cada 8 dones desenvoluparan un c\u00e0ncer de mama al llarg de la vida, el que significa que aquest c\u00e0ncer impacta cada any la vida de 2,1 milions de dones al m\u00f3n, segons l&#8217;OMS.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-3967 aligncenter\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/Card_DmCancerMama_CAT.jpg\" alt=\"\" width=\"400\" height=\"400\" srcset=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/Card_DmCancerMama_CAT.jpg 800w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/Card_DmCancerMama_CAT-300x300.jpg 300w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/Card_DmCancerMama_CAT-150x150.jpg 150w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/Card_DmCancerMama_CAT-768x768.jpg 768w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><\/p>\n<p>El gran problema d\u2019aquests tumors mamaris \u00e9s que poden derivar en met\u00e0stasi i causar la mort. Per sort, la taxa de superviv\u00e8ncia segueix augmentant gr\u00e0cies a la millora dels tractaments i a una detecci\u00f3 preco\u00e7 dels tumors.<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[519],"tags":[356,501,543,542,428,540,541],"class_list":["post-3972","post","type-post","status-publish","format-standard","hentry","category-investigacio","tag-assajos-clinics","tag-cancer-ca","tag-cancer-de-mama-ca","tag-cellules-tumorals","tag-metastasi","tag-prevencio","tag-tractaments"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>La Fundaci\u00f3 \u201dla Caixa\u201d, tamb\u00e9 en la lluita contra el c\u00e0ncer de mama - Blog CaixaCi\u00e8ncia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blog.caixaresearch.org\/ca\/la-fundacio-la-caixa-tambe-en-la-lluita-contra-el-cancer-de-mama\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La Fundaci\u00f3 \u201dla Caixa\u201d, tamb\u00e9 en la lluita contra el c\u00e0ncer de mama - Blog CaixaCi\u00e8ncia\" \/>\n<meta property=\"og:description\" content=\"El 2019 es van diagnosticar a Espanya 33.307 nous casos de c\u00e0ncer de mama. De fet, segons l\u2019Observatori del C\u00e0ncer AECC, des de l\u2019any 2012 fins al 2019 hi ha hagut un increment del 7,5 % dels casos i es calcula que 1 de cada 8 dones desenvoluparan un c\u00e0ncer de mama al llarg de la vida, el que significa que aquest c\u00e0ncer impacta cada any la vida de 2,1 milions de dones al m\u00f3n, segons l&#8217;OMS. El gran problema d\u2019aquests tumors mamaris \u00e9s que poden derivar en met\u00e0stasi i causar la mort. Per sort, la taxa de superviv\u00e8ncia segueix augmentant gr\u00e0cies a la millora dels tractaments i a una detecci\u00f3 preco\u00e7 dels tumors.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blog.caixaresearch.org\/ca\/la-fundacio-la-caixa-tambe-en-la-lluita-contra-el-cancer-de-mama\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog CaixaCi\u00e8ncia\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-19T07:31:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-23T11:16:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/Card_DmCancerMama_CAT.jpg\" \/>\n<meta name=\"author\" content=\"Ubikmedia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ubikmedia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/la-fundacio-la-caixa-tambe-en-la-lluita-contra-el-cancer-de-mama\/\",\"url\":\"https:\/\/blog.caixaresearch.org\/ca\/la-fundacio-la-caixa-tambe-en-la-lluita-contra-el-cancer-de-mama\/\",\"name\":\"La Fundaci\u00f3 \u201dla Caixa\u201d, tamb\u00e9 en la lluita contra el c\u00e0ncer de mama - Blog CaixaCi\u00e8ncia\",\"isPartOf\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/la-fundacio-la-caixa-tambe-en-la-lluita-contra-el-cancer-de-mama\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/la-fundacio-la-caixa-tambe-en-la-lluita-contra-el-cancer-de-mama\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/Card_DmCancerMama_CAT.jpg\",\"datePublished\":\"2020-10-19T07:31:17+00:00\",\"dateModified\":\"2021-03-23T11:16:09+00:00\",\"author\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/blog.caixaresearch.org\/ca\/la-fundacio-la-caixa-tambe-en-la-lluita-contra-el-cancer-de-mama\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/la-fundacio-la-caixa-tambe-en-la-lluita-contra-el-cancer-de-mama\/#primaryimage\",\"url\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/Card_DmCancerMama_CAT.jpg\",\"contentUrl\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/Card_DmCancerMama_CAT.jpg\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#website\",\"url\":\"https:\/\/blog.caixaresearch.org\/\",\"name\":\"Blog CaixaCi\u00e8ncia\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/blog.caixaresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca\",\"name\":\"Ubikmedia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g\",\"caption\":\"Ubikmedia\"},\"url\":\"https:\/\/blog.caixaresearch.org\/ca\/author\/ubikmedia\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La Fundaci\u00f3 \u201dla Caixa\u201d, tamb\u00e9 en la lluita contra el c\u00e0ncer de mama - Blog CaixaCi\u00e8ncia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blog.caixaresearch.org\/ca\/la-fundacio-la-caixa-tambe-en-la-lluita-contra-el-cancer-de-mama\/","og_locale":"ca_ES","og_type":"article","og_title":"La Fundaci\u00f3 \u201dla Caixa\u201d, tamb\u00e9 en la lluita contra el c\u00e0ncer de mama - Blog CaixaCi\u00e8ncia","og_description":"El 2019 es van diagnosticar a Espanya 33.307 nous casos de c\u00e0ncer de mama. De fet, segons l\u2019Observatori del C\u00e0ncer AECC, des de l\u2019any 2012 fins al 2019 hi ha hagut un increment del 7,5 % dels casos i es calcula que 1 de cada 8 dones desenvoluparan un c\u00e0ncer de mama al llarg de la vida, el que significa que aquest c\u00e0ncer impacta cada any la vida de 2,1 milions de dones al m\u00f3n, segons l&#8217;OMS. El gran problema d\u2019aquests tumors mamaris \u00e9s que poden derivar en met\u00e0stasi i causar la mort. Per sort, la taxa de superviv\u00e8ncia segueix augmentant gr\u00e0cies a la millora dels tractaments i a una detecci\u00f3 preco\u00e7 dels tumors.","og_url":"https:\/\/blog.caixaresearch.org\/ca\/la-fundacio-la-caixa-tambe-en-la-lluita-contra-el-cancer-de-mama\/","og_site_name":"Blog CaixaCi\u00e8ncia","article_published_time":"2020-10-19T07:31:17+00:00","article_modified_time":"2021-03-23T11:16:09+00:00","og_image":[{"url":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/Card_DmCancerMama_CAT.jpg","type":"","width":"","height":""}],"author":"Ubikmedia","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"Ubikmedia","Temps estimat de lectura":"5 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/blog.caixaresearch.org\/ca\/la-fundacio-la-caixa-tambe-en-la-lluita-contra-el-cancer-de-mama\/","url":"https:\/\/blog.caixaresearch.org\/ca\/la-fundacio-la-caixa-tambe-en-la-lluita-contra-el-cancer-de-mama\/","name":"La Fundaci\u00f3 \u201dla Caixa\u201d, tamb\u00e9 en la lluita contra el c\u00e0ncer de mama - Blog CaixaCi\u00e8ncia","isPartOf":{"@id":"https:\/\/blog.caixaresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blog.caixaresearch.org\/ca\/la-fundacio-la-caixa-tambe-en-la-lluita-contra-el-cancer-de-mama\/#primaryimage"},"image":{"@id":"https:\/\/blog.caixaresearch.org\/ca\/la-fundacio-la-caixa-tambe-en-la-lluita-contra-el-cancer-de-mama\/#primaryimage"},"thumbnailUrl":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/Card_DmCancerMama_CAT.jpg","datePublished":"2020-10-19T07:31:17+00:00","dateModified":"2021-03-23T11:16:09+00:00","author":{"@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blog.caixaresearch.org\/ca\/la-fundacio-la-caixa-tambe-en-la-lluita-contra-el-cancer-de-mama\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/blog.caixaresearch.org\/ca\/la-fundacio-la-caixa-tambe-en-la-lluita-contra-el-cancer-de-mama\/#primaryimage","url":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/Card_DmCancerMama_CAT.jpg","contentUrl":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/Card_DmCancerMama_CAT.jpg"},{"@type":"WebSite","@id":"https:\/\/blog.caixaresearch.org\/#website","url":"https:\/\/blog.caixaresearch.org\/","name":"Blog CaixaCi\u00e8ncia","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blog.caixaresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca","name":"Ubikmedia","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g","caption":"Ubikmedia"},"url":"https:\/\/blog.caixaresearch.org\/ca\/author\/ubikmedia\/"}]}},"_links":{"self":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/3972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/comments?post=3972"}],"version-history":[{"count":4,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/3972\/revisions"}],"predecessor-version":[{"id":4304,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/3972\/revisions\/4304"}],"wp:attachment":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/media?parent=3972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/categories?post=3972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/tags?post=3972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}